HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chantal Dreyer Selected Research

Growth Factor Receptors

6/2012Sunitinib in pancreatic neuroendocrine tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chantal Dreyer Research Topics

Disease

19Neoplasms (Cancer)
01/2018 - 01/2009
6Neuroendocrine Tumors (Neuroendocrine Tumor)
09/2012 - 08/2010
5Hepatocellular Carcinoma (Hepatoma)
04/2014 - 12/2009
2Carcinoma (Carcinomatosis)
01/2016 - 12/2010
2Hypertension (High Blood Pressure)
06/2012 - 01/2009
2Kidney Neoplasms (Kidney Cancer)
02/2012 - 01/2009
2Carcinogenesis
10/2010 - 08/2010
2Renal Cell Carcinoma (Grawitz Tumor)
08/2010 - 01/2009
1Biliary Tract Neoplasms (Biliary Tract Cancer)
09/2016
1Adenocarcinoma
07/2016
1Aneuploidy (Aneuploid)
07/2016
1Chromosomal Instability (Chromosome Stability)
07/2016
1Necrosis
04/2015
1Cholangiocarcinoma
04/2015
1Infections
11/2012
1Sepsis (Septicemia)
11/2012
1Septic Shock (Toxic Shock Syndrome)
11/2012
1Hand-Foot Syndrome
06/2012
1Diarrhea
06/2012
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
02/2012
1Pancreatic Neoplasms (Pancreatic Cancer)
08/2011
1Carcinoid Tumor (Carcinoid)
12/2010
1Neuroendocrine Carcinoma
12/2010
1Neoplasm Metastasis (Metastasis)
12/2010
1Colorectal Neoplasms (Colorectal Cancer)
10/2010
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
08/2010
1Disease Progression
01/2009
1Blister (Bulla)
01/2009
1Hypothyroidism
01/2009
1Fatigue
01/2009
1Asthenia
01/2009

Drug/Important Bio-Agent (IBA)

10Sunitinib (Sutent)FDA Link
01/2018 - 01/2009
4EverolimusFDA Link
06/2012 - 08/2010
3Biomarkers (Surrogate Marker)IBA
01/2018 - 07/2011
3GemcitabineFDA Link
09/2016 - 08/2011
3Sorafenib (BAY 43-9006)FDA Link
04/2014 - 07/2010
3Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
06/2012 - 12/2010
3TOR Serine-Threonine KinasesIBA
06/2011 - 08/2010
2Immune Checkpoint InhibitorsIBA
01/2017 - 03/2016
2Antineoplastic Agents (Antineoplastics)IBA
11/2012 - 12/2010
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2012 - 12/2010
2temsirolimusFDA Link
02/2012 - 08/2010
2Imatinib Mesylate (Gleevec)FDA Link
08/2010 - 01/2009
1PlatinumIBA
09/2016
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
07/2016
1DNA (Deoxyribonucleic Acid)IBA
07/2016
1Proteins (Proteins, Gene)FDA Link
07/2016
1IntegrinsIBA
07/2016
1Mitogen-Activated Protein KinasesIBA
03/2016
1DTS-108IBA
01/2016
1OligopeptidesIBA
01/2016
1EsterasesIBA
01/2016
1Irinotecan (Camptosar)FDA LinkGeneric
01/2016
1Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2015
1CoagulaseIBA
11/2012
1C-Reactive ProteinIBA
11/2012
1Growth Factor ReceptorsIBA
06/2012
1Sirolimus (Rapamycin)FDA Link
02/2012
1ridaforolimusIBA
02/2012
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
01/2012
1antineoplaston A10 (A 10)IBA
07/2011
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
06/2011
1Cyclin D1IBA
06/2011
1MTOR InhibitorsIBA
06/2011
1Fluorouracil (Carac)FDA LinkGeneric
10/2010
1Phosphotransferases (Kinase)IBA
08/2010
1Antihypertensive Agents (Antihypertensives)IBA
01/2009
1Thyroxine (Levothyroxine)FDA LinkGeneric
01/2009
1Tyrosine Kinase InhibitorsIBA
01/2009
1Thyroid HormonesIBA
01/2009

Therapy/Procedure

10Therapeutics
09/2016 - 01/2009
7Drug Therapy (Chemotherapy)
09/2016 - 07/2010
1Adjuvant Chemotherapy
09/2016
1Palliative Care (Palliative Therapy)
11/2012
1Drug Tapering
01/2009